Home › Employers › Accupath Diagnostic Laboratories, Inc.
Accupath Diagnostic Laboratories, Inc.: H-1B salaries and sponsorship
Accupath Diagnostic Laboratories, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $78,083.
Does Accupath Diagnostic Laboratories, Inc. sponsor H-1B visas?
Accupath Diagnostic Laboratories, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 8, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Cytogenetics Technologist | 2 | $81,775 |
| Senior Molecular Technologist | 1 | $59,530 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 3 | $78,083 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Senior Cytogenetics Technologist | $78,083–$87,610 Level IV | Phoenix, AZ | Sep 8, 2025 | Feb 24, 2026 | Certified |
| Senior Molecular Technologist | $59,530–$74,048 Level IV | Phoenix, AZ | May 27, 2025 | Jun 3, 2025 | Certified |
| Senior Cytogenetics Technologist | $85,467 Level IV | Phoenix, AZ | Jan 28, 2025 | Feb 24, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).